Archives - December 04, 2020

	Total Coronavirus cases in India surges past 95 Lakhs Covid Cases Cross 95 Lakhs in India, 90 Lakh recovered so far... Dec 04
	Karnataka releases Rs 300 crores for Covid-19 vaccine trials Karnataka prepares for vaccine tri... Dec 04
	AbbVie and Frontier Medicines establish global partnership for research and development The partnership will address novel therapies and E3 Degraders against difficult-to-drug targets... Dec 04
	Delivering quality, affordable and accessible health care in the UAE by Vikas Katoch, COO, Right Health ... Dec 04
	Make maximum use of digital technology says Anil Joshi, Managing Partner, Unicorn India Ventures ... Dec 04
	Catalyst Biosciences receives FDA Fast track designation for subcutaneous MarzAA MarzAA for the treatment of episodic bleeding in subjects with Hemophilia A or B with inhibitors ... Dec 04
	Gujarat records 1540 new cases of COVID-19 Gujarat reports fresh coronavirus cases from Ahmedabad and Surat... Dec 04
	COVID-19 recovery rate in Bihar improves to 97.12 pct In Bihar, the COVID-19 recovery rate has improved to 97.12 percent. This is 3.01 percent more than the national average.... Dec 04
	India’s Active Caseload further dips to 4.35% of Total Cases India’s active caseload has fallen to the 4.35% mark today from 4.44% yesterday.... Dec 04
	Britain to cover COVID-19 vaccine side-effects under damages scheme Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines under an existing program.... Dec 04
	Over 11,70,000 samples tested for COVID-19 across country in last 24 hours Over 11 lakh 70 thousand COVID samples were tested in the country in the last 24 hours. With this, the cumulative testing figure has reached ... Dec 04
	COVID-19 recovery rate in country improves to 94.20 pct India has leaped across a significant milestone in its fight against COVID. With the cumulative recovery of over 90 lakh people so far, the recovery ... Dec 04
	1450 new cases of COVID-19 reported in Madhya Pradesh In Madhya Pradesh, the number of COVID-19 cases in the state climbed up to around 2 lakh 10 thousand after 1450 new cases were ... Dec 04
	Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application Rhizen today announced the approval of IND application by the U.S. FDA to study its oral DHODH inhibitor for SARS-CoV-2 infection.... Dec 04
	PharmaEngine, Inc. collaborates with Sentinel Oncology for SOL-578, a Chk1 inhibitor PharmaEngine, Inc. and Sentinel Oncology Limited enter into an exclusive collaboration and license agreement for SOL-578, a Chk1 inhibitor ... Dec 04
	Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India Zydus Cadila, had received an approval from the Drugs Controller General of India to start the Phase 3 clinical trial in COVID-19 patients with ... Dec 04
	Study shows personalized provider navigation using machine intelligence may reduce post-surgical hospitalizations and lower costs The results showed that patients treated by hospitals ranked highly for a particular encounter by the machine intelligence–based algorithm experienced better health outcomes and ... Dec 04
	I2O Therapeutics receives strategic investment from Colorcon Ventures Colorcon will collaborate with i2O to accelerate i2O’s research and development efforts... Dec 04
	ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European ... Dec 04
	Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy Shape Therapeutics, announces today the unveiling of the AAVidTM capsid discovery platform and results from its first AAV5 variant library in a non-human primate ... Dec 04
	New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
	Odisha crosses milestone in conducting over 6 million tests for COVID-19 Odisha has crossed another milestone in conducting over 6 million tests for covid-19. ... Dec 04
	Telangana reports 631 fresh cases of COVID-19 Telangana reported 631 fresh COVID cases during the past 24 hours. With this, the total COVID cases reported in the state has gone up to ... Dec 04
	Covid technical Advisory panel advises Karnataka health dept to be prepared for 2nd wave of COVID-19 pandemic The Covid technical Advisory Committee in Karnataka has advised the state health department to be prepared to deal with a second wave of a pandemic ... Dec 04
24 Stories found!